Related Experiment Videos
CI-1015. An orally active CCK-B receptor antagonist with an improved pharmacokinetic profile
1Department of Medicinal Chemistry, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.
Abstract
No abstract available in PubMed .